Multiple Sclerosis often remains an invisible burden, largely due to limited public awareness, restricted access to specialised neurologists in Tier‑II and Tier‑III cities
Roche Pharma India, in collaboration with the Multiple Sclerosis Society of India (MSSI), presented Walk In My Shoes – a public health awareness initiative to highlight the often invisible struggles of individuals living with this life-limiting neurological condition.
“At Roche, our mission goes far beyond medicines. We are deeply committed to reimagining how chronic and life-altering conditions like Multiple Sclerosis are perceived, diagnosed, and managed,” said Rajji Mehdwan, Managing Director and CEO – India & Neighbouring Markets, Roche Pharma. “With #WalkInMyShoes, we are not just raising awareness, we are igniting empathy, amplifying patient voices, and driving meaningful change across the healthcare ecosystem. By partnering with MSSI, we are uniting science with compassion to break the silence around MS, champion timely intervention, and push for an inclusive, patient-centric approach where no individual living with MS is left behind. This is not just a campaign—it’s a clarion call to action.”
“Multiple Sclerosis often remains an invisible burden, largely due to limited public awareness, restricted access to specialised neurologists in Tier‑II and Tier‑III cities, and frequent mis or delayed diagnosis,” says Sandeep Chitnis, National Hon. Secretary – MSSI.
“MS is still one of the most complex and debilitating neurological diseases, especially since it tends to strike young adults at the prime of their youth,” stated Dr Ramesh Patankar, DM Neurology – Senior Consultant at SL Raheja Fortis Hospital, Mahim.
